Decreasing effects of iron toxicosis on selenium and glutathione peroxidase activity

Western Journal of Nursing Research

Volumn 24, Issue 2, 2002, Pages 119-131

  Bartfay, Wally J ^a   Bartfay, Emma ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE; SELENIUM;

ANIMAL; ARTICLE; CARDIOMYOPATHY; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DOSE RESPONSE; ENZYMOLOGY; HEART MUSCLE; IRON OVERLOAD; MALE; METABOLISM; MOUSE; MOUSE MUTANT; NURSING RESEARCH; RANDOMIZATION;

ANIMALS; CARDIOMYOPATHIES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE PEROXIDASE; IRON OVERLOAD; MALE; MICE; MICE, MUTANT STRAINS; MYOCARDIUM; NURSING RESEARCH; RANDOM ALLOCATION; SELENIUM;

EID: 0036513965     PISSN: 01939459     EISSN: None     Source Type: Journal    
DOI: 10.1177/01939450222045789     Document Type: Article

References (70)

1. Adams, P. C., & Valberg, L. S. (1996). Evolving expression of hereditary hemochromatosis. Seminars in Liver Disease, 16, 47-54.
2. Aldouri, M. A., Hoffbrand, A. V., Flynn, D. M., Ward, S. E., Agnew, J. E., & Hilson, A.J.W. (1994). High incidence of cardiomyopathy in beta-thalassemia patients receiving regular transfusions and iron chelation: Reversal by intensified chelation. Acta Haematology, 84, 113-123.
3. Andrews, N. C. (1999). Disorders of iron metabolism. The New England Journal of Medicine, 341, 1986-1995.
4. Arthur, J. R. (2000). The glutathione peroxidases. Cellular and Molecular Life Sciences, 57, 1825-1835.
5. Ball, A., & Sole, M. J. (1998). Oxidative stress and the pathogenesis of heart failure. Cardiology Clinics, 16, 665-675.
6. Bartfay, W. J., & Bartfay, E. (2000a). Iron-overload cardiomyopathy: Evidence for a free radical-mediated mechanism of injury and dysfunction in a murine model. Biological Research for Nursing, 2(1), 1-11.
7. Bartfay, W. J., & Bartfay, E. (2000b). Systemic oxygen-free radical production in iron-loaded mice. Western Journal of Nursing Research, 22, 927-935.
8. Bartfay, W. J., & Bartfay, E. (2001). Selenium and glutathione peroxidase with beta-thalassemia major. Nursing Research, 50(3), 178-183.
9. Bartfay, W. J., Butany, J., Lehotay, D. C., Sole, M. J., Hou, D., Bartfay, E., et al. (1999). A biochemical, histochemical, and electron microscopic study on the effects of iron-loading in heart of mice. Cardiovascular Pathology, 8(6), 305-314.
10. Bartfay, W. J., Dawood, F. D., Wen, W. H., Lehotay, D. C., Hou, D., Bartfay, E., et al. (1999). Cardiac function and cytotoxic aldehyde production in a murine model of chronic iron-overload. Cardiovascular Research, 43, 892-900.
11. Bartfay, W. J., Hou, D., Lehotay, D. C., Bartfay, E., Luo, X., & Liu, P. (2000). Cardioprotective effects of selenium and morin hydrate in a murine model of chronic iron overload. The Journal of Trace Elements in Experimental Medicine, 13, 285-297.
12. Bartfay, W. J., Lehotay, D. C., Sher, G. D., Bartfay, E., Tyler, B., Luo, X. P., et al. (1999). Comparison of cytotoxic aldehyde generation in beta-thalassemia patients chelated with deferoxamine or deferiprone (L1) versus no chelation. Hematology, 4, 67-76.
13. Bothwell, T. H., & MacPhail, A. P. (1998). Hereditary hemochromatosis: Etiologic, pathologic, and clinical aspects. Seminars in Hematology, 35, 55-71.
14. Burkitt, M. J., & Mason, R. P. (1991). Direct evidence for in vivo hydroxyl generation in experimental iron overload: An ESR spin-trapping investigation. Proceedings of the National Academy of Science, 88, 8440-8444.
15. Byler, R. M., Sherman, N. A., Wallner, J. S., & Horwitz, L. D. (1994). Hydrogen peroxide cytotoxicity is iron dependent. American Journal of Physiology, 35, H121-H127.
16. Chareonpong-Kawamoto, N., & Yasumoto, K. (1995). Selenium deficiency as a cause of overload of iron and unbalance distribution of other minerals. Bioscience, Biotechnology and Biochemistry, 59, 302-306.
17. Chau, L. Y. (2000). Iron and atherosclerosis. Proceedings of the National Science Council, 24(4), 151-155.
18. Chen, H., & Tappel, A. L. (1993). Protection of heme proteins by vitamin E, selenium, and betacarotene against oxidative damage in rat heart, kidney, lung and spleen. Free Radical Research Communications, 19, 183-190.
19. Chen, S. Y., Collipp, P. J., & Hsu, J. M. (1987). The effect of selenium toxicity on tissue distribution of zinc, iron, and copper in rats. In G. F. Combs, J. E. Spallholz, J. E., O. A. Levander, & J. E. Oldfied (Eds.), Selenium in biology and medicine (pp. 367-376). New York: Van Nostrand Reinhold.
20. Chyka, P. A., Butler, A. Y., & Holley, J. E. (1996). Serum iron concentrations and symptoms of acute iron poisoning in children. Pharmacotherapy, 16, 1053-1058.
21. Dabbagh, A. J., Mannion, T., Lynch, S. M., & Frei, B. (1994). The effect of iron overload on rat plasma and liver oxidant status in-vivo. Biochemistry Journal, 300, 799-803.
22. Demougeot, C., Marie, C., & Beley, A. (2000). Importance of iron location in iron-induced hydroxyl radical production by brain slices. Life Sciences, 67, 399-410.
23. Der, G., & Everitt, D. (2001). A handbook of statistical analysis using SAS (2nd ed). Boca Raton, FL: Chapman & Hall/CRC Press.
24. Dworkin, B. M. (1994). Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chemico-Biology International, 91, 181-186.
25. Feder, J. N., Gnirke, A., & Thomas, W. (1996). A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics, 13, 399-408.
26. Fenton, H.J.H. (1894). Oxidation of tartaric acid in the presence of iron. Journal of Chemical Society, 65, 899-903.
27. Frost, D. V. (1980). Selenium and vitamin E as antidotes to heavy metal toxicities. In J. E. Spallholz, J. L. Martin, & H. E. Ganther (Eds.), Selenium in biology and medicine (pp. 490-498). Westport, CT: AVI.
28. Goyer, R. A. (1995). Nutrition and metal toxicity. American Journal of Clinical Nutrition, 61, 646S-650S.
29. Haber, F., & Weiss, J. (1934). The catalytic decomposition of hydrogen peroxide by iron salts. Proceedings of the Royal Society London, 147(Series A), 332-351.
30. Halliwell, B. (1997). Antioxidants and human disease: A general introduction. Nutrition Reviews, 55, S44-S52.
31. Halliwell, B., & Gutteridge, J.M.C. (1990). Role of free radicals and catalytic metal ions in human disease. An overview. Methods in Enzymology, 186, 1-85.
32. Herbert, V., Shaw, S., Jayatilleke, E., & Stopler-Kasdan, T. (1994). Most free radical injury is iron-related. It is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin. Stem Cells, 12, 289-303.
33. Hershko, C., Link, G., & Cabantchik, I. (1998). Pathophysiology of iron overload. Annuals of the New York Academy of Sciences, 850, 191-201.
34. Horwitz, D. L., & Rosenthal, E. A. (1999). Iron-mediated cardiovascular injury. Vascular Medicine, 4, 93-99.
35. Houglum, K., Filip, M., Witztum, J., & Chojkier, M. (1991). Malondialdehyde and 4-hydroxynoneneal protein adducts in plasma of rats with iron overload. Journal of Clinical Investigations, 86, 1991-1998.
36. Kehrer, J. P. (2000). The Haber-Weiss reaction and mechanisms of toxicity. Toxicology, 149, 43-50.
37. Kennedy, S., & Rice, D. A. (1989). Selective damage to cardiac conduction system in vitamin E and selenium deficient calves. Annuals of the New York Academy of Sciences, 570, 467-469.
38. Knowles, M. B., & Brodie, K. G. (1988). Determination of selenium in blood by Zeeman graphic furnace atomic absorption spectrometry using palladium-ascorbic acid chemical modifier. Journal of Analytical Atomic Spectrometry, 3, 511-516.
39. Konz, K. H., Haap, M., Hill, K. E., Burk, R. F., & Walsh, R. A. (1989). Diastolic dysfunction of perfused rat hearts induced by hydrogen peroxide. Protective effect of selenium. Journal of Molecular and Cellular Cardiology, 21, 789-795.
40. Lawrence, D., & Rosenthal, E. A. (1999). Iron-mediated cardiovascular injury. Vascular Medicine, 4, 93-99.
41. Lesnefsky, E. J. (1994). Tissue iron overload and mechanisms of iron-catalyzed oxidative injury. Advances in Experimental Medicine and Biology, 366, 129-146.
42. Liu, P., Henkleman, R.M., Joshi, J., Hardy, P., Butany, J., Iwanochko, M., et al. (1996). Quantification of cardiac and tissue iron by nuclear magnetic resonance relaxometry in a novel thalassemia-cardiac iron overload model. Canadian Journal of Cardiology, 12, 155-164.
43. Liu, P., & Olivieri, N. (1994). Iron overload cardiomyopathies: New insights into an old disease. Cardiovascular Drugs and Therapy, 8, 101-110.
44. Livrea, M. A., Tesoriere, L., Pintaudi, A. M., Calabrese, A., Maggio, A., Freisleben, H. J., et al. (1996). Oxidative stress and antioxidant status in beta-thalassemia major: Iron overload and depletion of lipid soluble antioxidants. Blood, 88, 3608-3614.
45. Lockitch, G., Taylor, G. P., & Wong, L.T.K. (1990). Cardiomyopathy associated with nonendemic selenium deficiency in a Caucasian adolescent. American Journal of Clinical Nutrition, 52, 572-577.
46. Lynch, S. R. (1995). Iron-overload: Prevalence and impact on health. Nutrition Reviews, 53, 255-260.
47. Madani, T.A.A., & Bormanis, J. (1997). Reversible severe hereditary hemochromatotic cardiomyopathy. Canadian Journal of Cardiology, 13(4), 391-394.
48. McCord, J. M. (1996). Effects of iron status at a cellular level. Nutrition Reviews, 54, 85-88.
49. McMaster, D., Bell, N., Anderson, P., & Hg-Love, A. (1990). Automated measurements of two indicators of human selenium status and applicability to population study. Clinical Chemistry, 36, 211-216.
50. Meneghini, R. (1997). Iron homeostasis, oxidative stress, and DNA damage. Free Radical Biology and Medicine, 23, 783-792.
51. Montgomery, D. C. (1991). Design and analysis of experiments (3rd ed.). New York: John Wiley.
52. Myers, M. L., Farhangkhoee, P., & Karmazyn, M. (1998). Hydrogen peroxide induced impairment of post-ischemic ventricular function is prevented by the sodium-hydrogen exchange inhibitor HOE 642. Cardiovascular Research, 40, 290-296.
53. Olfert, E. D., Cross, B. M., & McWilliams, A. A. (1993). Canadian Council on Animal Care: Guide to the care and use of experimental animals (2nd ed.). Ottawa, Ontario: Bradda Printing Services.
54. Olivieri, N. F. (1999). The β-thalassemias. The New England Journal of Medicine, 341(2), 99-109.
55. Olivieri, N. F., & Brittenham, G. M. (1997). Iron-chelating therapy and the treatment of thalassemia. Blood, 89, 281-284.
56. Parkkila, S., Niemela, O., Britton, R. S., Brown, K. E., & Yla-Herttuala, S. (1996). Vitamin E decreases hepatic levels of aldehyde-derived peroxidation products in rats with iron-overload. American Journal of Physiology, 270, G376-G384.
57. Persson-Moschos, M. (2000). Selenoprotein P. Cellular and Molecular Life Sciences, 57, 1836-1845.
58. Pucheu, S., Coudray, C., Tressallet, N., Favier, A., & de Leins, J. (1993). Effect of iron overload in the isolated ischemic and reperfused rat heart. Cardiovascular Drugs and Therapy, 7,701-711.
59. Quercia, R. A., Korn, S., O'Neill, D., Dougherty, J. E., Ludwig, M., Schweizer, R., et al. (1984). Selenium deficiency and fatal cardiomyopathy in a person receiving long-term home parenteral nutrition. Clinical Pharmacology, 3, 531-535.
60. Read, R., Bellew, T., Yang, J. G., Hill, K. E., Palmer, I. S., & Burk, R. F. (1990). Selenium and ami no acid composition of selenoprotein P, the major selenoprotein in rat serum. Journal of Biology and Chemistry, 265, 17899-17905.
61. Ringstad, J., Tande, P. M., Norheim, G., & Refsum, H. (1988). Selenium deficiency and cardiac electrophysiological and mechanical function in the rat. Pharmacology and Toxicology, 63, 189-192.
62. Sasakura, C., & Suzuki, K. T. (1998). Biological interaction between transition metals (Ag, Cd and Hg), selenide/sulfide and selenoprotein P. Journal of Inorganic Biochemistry, 71(3-4), 159-162.
63. Simoni, J., Simoni, G., Barcia, E. L., Prien, S.D., Tran, R. M., Feola, M., et al. (1995). Protective effect of selenium on hemoglobin mediated lipid peroxidation in-vivo. Artificial Cells, Blood Substitutes and Immobilization Biotechnology, 23, 469-486.
64. Singal, P. K., Khaper, N., Palace, V., & Kumar, D. (1998). The role of oxidative stress in the genesis of heart disease. Cardiovascular Research, 40, 426-432.
65. Westfall, P. H., Tobias, R. D., Rom, D., Walfinger, R. D., & Hochberg, Y. (1999). Multiple comparisons and multiple tests using the SAS system. Gary, NC: SAS Publications.
66. Whanger, P. D. (1993). Selenium in the treatment of heavy metal poisoning and chemical carcinogenesis. Journal of Trace Elements, Electrolytes, Health and Disease, 6, 209-221.
67. Whanger, P. D. (2000). Selenoprotein W: A review. Cellular and Molecular Life Sciences, 57, 1846-1845.
68. Young, I. S., Trouton, T. G., Torney, J. J., McMaster, D., Callender, M., & Trimble, E. R. (1994). Antioxidant status and lipid peroxidation in hereditary hemochromatosis. Free Radical Biology and Medicine, 16, 393-397.
69. Ytrehus, K., Ringstad, J., Myklebust, R., Norheim, G., & Mjos, O. D. (1988). The selenium-deficient rat heart with special reference to tolerance against enzymatically generated oxygen radicals. Scandinavian Journal of Clinical and Laboratory Investigations, 48,289-295.
70. Zachara, B. (1992). Mammalian selenoproteins. Journal of Trace Element, Electrolytes, Health and Disease, 6, 137-151.